Axon Enterprise
AXON
#542
Rank
โ‚ฌ37.47 B
Marketcap
474,85ย โ‚ฌ
Share price
0.39%
Change (1 day)
-21.92%
Change (1 year)

Revenue for Axon Enterprise (AXON)

Revenue in 2025 (TTM): โ‚ฌ2.28 Billion

According to Axon Enterprise 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.19 Billion. In 2024 the company made a revenue of โ‚ฌ2.00 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ1.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Axon Enterprise from 2001 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ2.28 B14.1%
2024 โ‚ฌ2.00 B41.54%
2023 โ‚ฌ1.41 B27.46%
2022 โ‚ฌ1.10 B45.51%
2021 โ‚ฌ0.76 B37.69%
2020 โ‚ฌ0.55 B16.84%
2019 โ‚ฌ0.47 B29.06%
2018 โ‚ฌ0.36 B28.15%
2017 โ‚ฌ0.28 B12.36%
2016 โ‚ฌ0.25 B40.91%
2015 โ‚ฌ0.18 B33.79%
2014 โ‚ฌ0.13 B35.54%
2013 โ‚ฌ99.8 M15.05%
2012 โ‚ฌ86.75 M25.14%
2011 โ‚ฌ69.32 M6.07%
2010 โ‚ฌ65.35 M-10.18%
2009 โ‚ฌ72.76 M9.56%
2008 โ‚ฌ66.41 M-3.73%
2007 โ‚ฌ68.98 M34.42%
2006 โ‚ฌ51.32 M27.47%
2005 โ‚ฌ40.26 M-19.26%
2004 โ‚ฌ49.86 M156.7%
2003 โ‚ฌ19.42 M106.3%
2002 โ‚ฌ9.41 M21.34%
2001 โ‚ฌ7.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
XBiotech
XBIT
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ86.19 M-96.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ28.22 M-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ1.96 B-10.55%๐Ÿ‡บ๐Ÿ‡ธ USA